Search research articles
Contact Us
Filters
Showing results (1111-1120 of 1,203) with videos related to
Page
of 121
Sort By:
European Urology
|
October 29, 2015
Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies
Joaquim Bellmunt, Thian Kheoh, Margaret K Yu, et al.
JCO Precision Oncology
|
January 31, 2025
Digital Pathology-Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer
Felix Y Feng, Matthew R Smith, Fred Saad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 23, 2022
CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease
Ning Zhao, Shalini Chopra, Kai Trepka, et al.
Transplantation and Cellular Therapy
|
May 17, 2022
Change in Patients' Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma
Anna Barata, Aasha I Hoogland, Anuhya Kommalapati, et al.
Breast Cancer Research and Treatment
|
September 13, 2021
Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors
A Dilawari, K E Rentscher, W Zhai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2023
Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial
K N Chi, S Sandhu, M R Smith, et al.
Journal of Pain and Symptom Management
|
November 26, 2018
Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors
Danielle B Tometich, Brent J Small, Judith E Carroll, et al.
Journal of Geriatric Oncology
|
August 27, 2022
Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study
Kathleen Van Dyk, Jaeil Ahn, Xingtao Zhou, et al.
Frontiers in Oncology
|
March 24, 2022
APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer
Divya Natesan, Li Zhang, Henry J Martell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2020
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer
James A Eastham, Glenn Heller, Susan Halabi, et al.
Page
of 121
Search research articles
Search
Showing results (1111-1120 of 1,203) with videos related to
Sort By:
Page
of 121
European Urology
|
October 29, 2015
Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies
Joaquim Bellmunt, Thian Kheoh, Margaret K Yu, et al.
JCO Precision Oncology
|
January 31, 2025
Digital Pathology-Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer
Felix Y Feng, Matthew R Smith, Fred Saad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 23, 2022
CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease
Ning Zhao, Shalini Chopra, Kai Trepka, et al.
Transplantation and Cellular Therapy
|
May 17, 2022
Change in Patients' Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma
Anna Barata, Aasha I Hoogland, Anuhya Kommalapati, et al.
Breast Cancer Research and Treatment
|
September 13, 2021
Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors
A Dilawari, K E Rentscher, W Zhai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2023
Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial
K N Chi, S Sandhu, M R Smith, et al.
Journal of Pain and Symptom Management
|
November 26, 2018
Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors
Danielle B Tometich, Brent J Small, Judith E Carroll, et al.
Journal of Geriatric Oncology
|
August 27, 2022
Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study
Kathleen Van Dyk, Jaeil Ahn, Xingtao Zhou, et al.
Frontiers in Oncology
|
March 24, 2022
APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer
Divya Natesan, Li Zhang, Henry J Martell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2020
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer
James A Eastham, Glenn Heller, Susan Halabi, et al.
Page
of 121